Cargando…

Innovative electrochemical electrode modified with Al(2)O(3) nanoparticle decorated MWCNTs for ultra-trace determination of tamsulosin and solifenacin in human plasma and urine samples and their pharmaceutical dosage form

A simple, cheap, sensitive, and time-saving square wave voltammetric (SWV) procedure using a carbon paste electrode modified with aluminum oxide nanoparticle decorated multi-walled carbon nanoparticles (Al(2)O(3)-NPs/MWCNTs/CPE) is presented for the ultra-sensitive determination of tamsulosin (TAM)...

Descripción completa

Detalles Bibliográficos
Autores principales: Attia, Khalid A. M., Abdel-Raoof, Ahmed M., Serag, Ahmed, Eid, Sherif M., Abbas, Ahmed E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192163/
https://www.ncbi.nlm.nih.gov/pubmed/35765456
http://dx.doi.org/10.1039/d2ra01962k
Descripción
Sumario:A simple, cheap, sensitive, and time-saving square wave voltammetric (SWV) procedure using a carbon paste electrode modified with aluminum oxide nanoparticle decorated multi-walled carbon nanoparticles (Al(2)O(3)-NPs/MWCNTs/CPE) is presented for the ultra-sensitive determination of tamsulosin (TAM) and solifenacin (SOL), one of the most prescribed pharmaceutical combinations in urology. Characterization of the developed electrode was performed using scanning electron microscopy (SEM), X-ray diffraction (XRD) patterns, energy dispersive X-ray analysis (EDX), transmission electron microscopy (TEM) and FT-IR spectrophotometry. The voltammetric behavior of TAM/SOL was evaluated using Al(2)O(3)-NPs in different content and electrode compositions. The use of Al(2)O(3) functionalized MWCNTs as a CPE modifier increased the process of electron transfer as well as improved the electrode active surface area therefore, ultra-sensitive results were acquired with a linear range of 10–100 and 12–125 ng ml(−1) for TAM and SOL respectively, and a limit of the detection value of 2.69 and 3.25 ng ml(−1) for TAM and SOL, respectively. Interestingly, the proposed method succeeded in quantifying TAM and SOL with acceptable percentage recoveries in dosage forms having diverged concentration ranges and in the biological fluids with very low peak plasma concentration (C(max)). Furthermore, the proposed method was validated, according to the ICH criteria, and shown to be accurate and reproducible.